Product Information

ZONISAMIDE 50 MG CAPSULE is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.0982 per EA under NDC 68462012901. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jan 30, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ZONISAMIDE 50 MG CAPSULE

Zonisamide
$0.0982per EA

Strength

50 mg/1

NDC

68462012901

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ZONISAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA077651

FDA Approved

1/30/2006

TE Code

AB

On Market Since

1/30/2006

Pharmacological Classes

Anti-epileptic Agent
Carbonic Anhydrase Inhibitors
Decreased Central Nervous System Disorganized Electrical Activity
P-Glycoprotein Inhibitors
Sulfonamides

Price Statistics

The NADAC for ZONISAMIDE 50 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 12.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0982 per EA
All-time high$0.2424 (Sep 10, 2014)
All-time low$0.0679 (Jul 17, 2024)
52-week high$0.0984
52-week low$0.0948
Median price$0.1297
Average price$0.1276
Largest weekly change+39.5% (Aug 21, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+3.6%

1M

+3.6%

3M

+1.1%

6M

+0.9%

1Y

+2.7%

3Y

-0.0%

5Y

-18.1%

All

-12.9%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ZONISAMIDE 50 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ZONISAMIDE 50 MG CAPSULE, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.0982 per EA (NDC 68462012901), effective Aug 19, 2026.

How has the price of ZONISAMIDE 50 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for ZONISAMIDE 50 MG CAPSULE has declined 12.9%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ZONISAMIDE 50 MG CAPSULE?

Since Nov 28, 2013, the NADAC for ZONISAMIDE 50 MG CAPSULE has ranged from a low of $0.0679 (Jul 17, 2024) to a high of $0.2424 (Sep 10, 2014), with a median of $0.1297 per EA.

Are there cheaper alternatives to ZONISAMIDE 50 MG CAPSULE?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZONISAMIDE 50 MG CAPSULE, is $0.0974 per EA — about 1% below ZONISAMIDE 50 MG CAPSULE.

Who manufactures ZONISAMIDE 50 MG CAPSULE?

ZONISAMIDE 50 MG CAPSULE (NDC 68462012901) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.